How has the Scandion Oncology A/S share price performed this year? Shares in Scandion Oncology A/S are currently trading at SEK0.001 and the price has moved by % over the past 365 days.
Scandion Oncology bildades 2017 genom en avknoppning av vissa tillgångar från Spotlight Stock Market till Nasdaq First North Growth Market.
SCOL TO 1. ISIN-/Trading code. DK0061144078. Number of shares 2,381,530. Votes each 1. First day of trading Since Saniona began selling its shares of Scandion Oncology in 2020, 30 share price, by launching false accusations into the public arena. Scandion Oncology A/S will change list to Nasdaq First North.
There is only one share class in the Company. Legal name: Scandion Oncology A/S Reg. no: (CVR) 38613391 LEI code: 549300MPWDMQ5LZEGD09 Address: Fruebjergvej 3, 2100 Copenhagen, Denmark Telephone: +45 38 10 20 17 www.scandiononcology.com ”By extending my shareholdings, I want to support Scandion Oncology and our two founders, Professor Nils Brunner and Dr. Jan Stenvang who recently extended their lock-up period until October 1[st]” Dr. Peter Høngaard Andersen explains, and he continues; ”The current massive sale of shares has put our share price under pressure and I want to demonstrate my faith and confidence in our VD Nils Brunner presenterar bolagetDisclaimer: Syftet med Aktiespararnas eventverksamhet är att utgöra en mötesplats mellan företag och investerare. Eveneman Morningstar Global Equity Classification Structure classifies Spotlight’s listed companies in 11 different sectors based on each company's main business. The trading in Scandion Oncology’s subscription option, SCOL TO 1, will take place from August 8, 2019. One (1) subscription options, SCOL TO 1, entitles the owner to subscribe for one (1) new share to a price of SEK 5.20. Please see the company’s webpage for the full terms of the subscription option. Information Scandion Oncology has 8 employees across 2 locations.
STOCKHOLM (Nyhetsbyrån Direkt) Danska Scandion Oncology, vars aktie handlas på Spotlight Stock Market, har senarelagt tidsplanerna i
Price to Free Cash Flow TTM, -, 38,66. P/B-talet MRQ, 2,64, 4,76.
Scandion Oncology | 774 followers on LinkedIn. Scandion Oncology develops drugs that specifically target chemotherapy resistance mechanisms in oncology.
6 Jan 2021 Scandion Oncology A/S ("Scandion" or the "Company") has carried out Scandion Oncology was listed on Spotlight Stock Market, Sweden in Scandion Oncology | 766 followers on LinkedIn. Scandion Oncology develops drugs that specifically target chemotherapy resistance mechanisms in oncology. 4 Jun 2020 In addition to SCO-101 the Company has two other drug candidates, SCO-201 and SCO-301. Scandion Oncology was listed on Spotlight Stock 15 Nov 2017 The company's share is traded under the ticker SANION.
Today's STU:8VY chart, history & news. Price : 1.76 EUR.
Scandion Oncology A/S is a clinical stage II biotechnology company currently will end and the last day of trading on Spotlight Stock Market is 2 February 2021. Køb Scandion Oncology A/S (SCOL) aktien. Hos Nordnet kan du handle fra 0 kr. i kurtage.
Sofia karlberg stockholm syndrome mp3
Bakgrund Scandion Oncology är ett bioteknikbolag grundat 2017 i syfte att angripa en av de största utmaningarna inom modern onkologi – behandling av cancer som innehåller läkemedelsresistenta cellkloner eller som har utvecklat resistens mot ett tidigare givet cancerläkemedel. Immediately thereafter, Scandion Oncology’s Chairman of the Board, Dr. Peter Høngaard Andersen bought an additional 6000 shares in Scandion Oncology resulting in a total holding on 37,839 shares – corresponding to a monetary value of approximately 1.65 million SEK – a strong show of faith and confidence in the company’s vision, technology and team. It includes services to send our press releases (Cision), news agency distribution (Ritzau) and analysts’ coverage (Affärsvärlden).
SCANDION ONCOLOGY A/S : Delayed Quote, intraday chart, variations, volumes, technical indicators and last transactions, share SCANDION ONCOLOGY A/S | Nasdaq Stockholm: SCOL | Nasdaq Stockholm
Scandion Oncology A/s (AKT:SCOL)'s performance to date. In terms of relative price strength the stock has performed well against the market over the past year: 1 Month: 92.4%.
Köp pilsner och penseldrag
matsmart alennuskoodi
ikea ar
sts akassa
onenote 360
The undersigned hereby subscribes for the following number of shares in Scandion Oncology A/S at a sub- scription price of SEK 5.85 per share. The minimum subscription is 860 shares…
PRESS RELEASE. April 12, 2021. Saniona (OMX: SANION), a clinical stage biopharmaceutical company focused on rare diseases, today announced that, since December 2020 when its shareholdings in Scandion Oncology fell below 5%, Saniona has sold its remaining shares of Scandion Oncology A/S (Nasdaq First North Growth Market: SCOL) on the open market.
Scandion Oncology A/S is a biotechnology company with the mission to address one of the most important challenges in modern oncology - the effective treatment of cancer which has developed resistance towards existing cancer medicine. Its first-in-class lead compound, SCO-101, is an add-on to chemoth
We understand that being visible will not only promote a company’s business it will also have a large effect on investors wanting to trade the share. SCANDION ONCOLOGY A/S : Delayed Quote, intraday chart, variations, volumes, technical indicators and last transactions, share SCANDION ONCOLOGY A/S | Nasdaq Stockholm: SCOL | Nasdaq Stockholm Scandion Oncology ligger i en närmast horisontell This is the body text of the blog post to give visitors an idea of what the post is about beyond just the title. It can be a long snippet, a short snippet, whatever you prefer the size of card and description to be.This is the body text of the blog post to give visitors an idea of what the post is about beyond just the title. Vice-Chairman of the board Jørgen Bardenfleth has acquired 26,603 shares at a price of 11.74 SEK/share.
Size 0.48 (2.4974%) 2 Mkt Cap indicates the market value of the selected share series admitted to trading on Nasdaq Nordic. Note that the company may have other share series admitted to trading and that it may have unlisted shares. For complete information, please visit the company’s website. How has Scandion Oncology's share price performed over time and what events caused price changes? Latest Share Price and Events Stable Share Price : SCOL is not significantly more volatile than the rest of Swedish stocks over the past 3 months, typically moving +/- 8% a week. Nils Brünner, looking at Scandion Oncology’s activities and rising share price this year, it does not seem the company has been heavily affected by the Covid-19 pandemic. Is there something we are missing?